Private Capital

Topics also related to Private Capital Sections:

MOVES-Charles Schwab, LGM Investments, Bank of Cyprus, Morgan Stanley

(Adds Charles Schwab, Morgan Stanley and New York City Comptroller)

Deals of the day- Mergers and acquisitions

(Naspers, Club Med, Obi, Aviva Plc, Korea Gas Corp, UniCredit)

MOVES-Top sports banker Cornwell to join Taubman's new firm -source

Nov 21 - Don Cornwell, a banker who advised the Buffalo Bills NFL team on their sale earlier this year, is leaving Morgan Stanley to join the new advisory firm headed by investment banker Paul Taubman, according to a person familiar with the matter.

TRLPC-Confusion over leveraged loans despite regulators' insight

NEW YORK, Nov 21 - Regulators' attempts to clarify U.S. leveraged lending guidelines have answered some questions raised by banks, but also added fresh layers of complexity into loan underwriting decisions, banking sources said.

Financials 21 Nov 2014

Scientific Games, Tibco puts spotlight on overlevered LBOs

NEW YORK, Nov 21 (IFR/TRLPC) - Banks are not shying away from underwriting highly leveraged buyouts even as the buyside balks at some recent deals deemed to have too much debt and regulators continue to warn lenders to keep leverage levels in check.

UPDATE 2-Dow Chemical, Dan Loeb settle board debate

Nov 21 - Dow Chemical Co averted a proxy fight with Dan Loeb's hedge fund, Third Point LLC, by agreeing to add four independent directors to its board, sending its shares up as much as 4.5 percent.

CORRECTED-BRIEF-Valeant Pharma reports 0.1 percent stake in Allergan

(Corrects first bullet point to remove incorrect reference to Valeant's prior stake in Allergan)

Advent now majority owner of Towergate

LONDON, Nov 21 (IFR) - Towergate told its bondholders on Friday that private equity firm Advent is now the majority owner of the troubled UK insurance broker, confirming a report from IFR earlier in the week.

IPOs, Financials 21 Nov 2014

CORRECTED-Valeant slashes stake in Allergan after losing bid

Nov 20 - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.


Pariatur Quisquam Magni Magni

Ut Odit Et Architecto Sed Laudantium Ullamco. Reprehenderit Eius Iste Ab Minima. Nihil Aut Odit Magni Amet Aperiam Laudantium.

Topics also related to Private Capital: